Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Flavin mononucleotide
Drug ID BADD_D02447
Description A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.
Indications and Usage Not Available
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB03247
KEGG ID Not Available
MeSH ID D005486
PubChem ID 643976
TTD Drug ID D00IBG
NDC Product Code Not Available
UNII 7N464URE7E
Synonyms Flavin Mononucleotide | Mononucleotide, Flavin | Riboflavin 5'-Phosphate | 5'-Phosphate, Riboflavin | Riboflavin 5' Phosphate | Riboflavin 5'-Monophosphate | 5'-Monophosphate, Riboflavin | Riboflavin 5' Monophosphate | FMN | Riboflavin Mononucleotide | Mononucleotide, Riboflavin | Flavin Mononucleotide Sodium Salt | Sodium Riboflavin Phosphate | Phosphate, Sodium Riboflavin | Riboflavin Phosphate, Sodium | Flavin Mononucleotide Monosodium Salt, Dihydrate | Flavin Mononucleotide Disodium Salt | Flavin Mononucleotide Monosodium Salt
Chemical Information
Molecular Formula C17H21N4O9P
CAS Registry Number 146-17-8
SMILES CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Corneal epithelium defect06.06.03.012--
Corneal infiltrates06.08.01.002--
Corneal oedema06.04.02.001--
Corneal opacity06.06.03.005--
Corneal perforation06.06.03.006; 12.01.04.003--
Corneal scar06.06.03.015; 12.01.04.015--
Discomfort08.01.08.003--
Dry eye06.08.02.001-
Eye pain06.08.03.002-
Keratitis06.04.02.002-
Visual acuity reduced06.02.10.012; 17.17.01.011-
Visual impairment06.02.10.013--
Corneal striae06.06.03.011--
Ocular discomfort06.08.03.008--
Corneal thinning06.06.03.009--
Corneal disorder06.08.01.004--
Disease progression08.01.03.038-
Ulcerative keratitis06.04.02.004; 10.02.01.021-
Instillation site dryness08.02.01.060; 12.07.01.060--
Therapeutic product effect decreased08.06.01.050--
The 1th Page    1    Total 1 Pages